Twitxy Saved

Philip Schauer, MD

Verified account This account is verified. Learn more

@PSchauerMD

Professor of Metabolic Surgery, Director Metamor Institute, Pennington Biomedical Research Center of Louisiana State University
Baton Rouge, LA metamorinstitute.org Joined September 2015
897 Following 6.8K Followers 5.5K Posts

Latest posts 5

Philip Schauer, MD Verified account @PSchauerMD
This estimate is too low. Actually, more than 200 comorbid conditions have been improved or resolved following metabolic surgery. @IfsoSecretariat @asmbs @NeilFlochMD @Jmortonmd @jdscottmd @ColleenKennedyD @Ali_Aminian_MD @metabolic_knife @mattars77 @matthew_kroh @JaimePonceMD @PaulinaSalminen @marinakurian
IFSO @IfsoSecretariat 2d
Obesity is a chronic disease that can affect almost every system in the body.
METABOLIC BARIATRIC SURGERY improves more than 40 obesity-related diseases and conditions. Treating obesity means caring for the whole body.
View quoted post on X
1 replies 5 reposts 10 likes 586 views View on X
Philip Schauer, MD Verified account @PSchauerMD
Metabolic Bariatric Surgery's Safety Problem: A Messaging Opportunity, Not Just a Clinical One. The problem is the PERCEPTION of safety. National data indicates MBS safer than MOST abdominal surgery including gallbladder surgery, hernia, hysterectomy, appendectomy, hiatal hernia BUT also extends life! mbs-digest.com/p/editorial-me… @shanu_kothari @mattars77 @JerryDangMD @TeresaLamasters @NeilFlochMD @JaimePonceMD @metabolic_knife @Ali_Aminian_MD
www.mbs-digest.com Metabolic Bariatric Surgery Safety: Editorial Shanu N. Kothari, MD, FACS, on why metabolic bariatric surgery is still perceived as high-risk and how reported 30-day mortality compares with ventral hernia repair.
2 replies 8 reposts 23 likes 1.1K views View on X
Philip Schauer, MD Verified account @PSchauerMD
The point is, why wait? You’ll never get long-term remission with medical therapy. Why deny a patient the opportunity?
Jack Verified account @ShenyunMedical Oct 31
@PSchauerMD @AmDiabetesAssn @ADA_DiabetesPro @TheAACE The duration gradient (75% at 1–4.9 yrs vs 36% at 10+) is a strong case for earlier referral, with the caveat that it's observational within the randomized arms. Could C-peptide or insulin start help endocrinologists flag who is running out of time?
View quoted post on X